select a format

Single User License
USD 250 INR 16198
Site License
USD 500 INR 32395
Corporate User License
USD 750 INR 48593

Alternatively

Request a quote
Request a Customized research
Request for Sample Report





Recent Viewed Reports


Why Ken Reasearch?


Testimonials

This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ... "Mohit Mittal, Consultant, KPMG Advisory Services"

I am pleased to see the very useful and productive information in the report..Very well structured great presentation reflect professionalism in your research studies.... "Mustafa Masood, Financial Analyst , Coldwell Banker Riyadh"

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ... "Prashant Bhagwat,General Manager, Mahindra"

We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!... "Jestin Mathew, Indonesian Trade Promotion Center"

The Report was very interesting and useful for me... "Marketing Manager, Western Union Business Solutions"


CareDx Inc (CDNA)-Medical Equipment-Deals and Alliances Profile

CareDx Inc (CDNA)-Medical Equipment-Deals and Alliances Profile


  • Products Id :- GDME26721D
  • |
  • Pages: 51
  • |
  • July 2017
  • |
  • |
  Request for Sample Report

Executive Summary

CareDx Inc (CareDx) formerly XDx Inc, is a commercial stage molecular diagnostics company that develops, markets, and delivers diagnostic surveillance solutions for heart transplant patients. The company offers commercialized testing solution, the AlloMap heart transplant molecular test, is a noninvasive blood test used which helps clinicians to monitor and identify acute cellular rejection in heart transplant recipients. It develops products for transplant monitoring including AlloSure, a next-generation sequencing test to detect donor-derived cell-free DNA after transplantation. CareDx uses genomics and bioinformatics technology to develop its products. It offers novel surveillance management solutions to transform long-term patient care in transplantation. CareDx is headquartered in Brisbane, California, the US.

CareDx Inc (CDNA)-Medical Equipment-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

Financial Deals-Analysis of the company financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

Major Deals-Information on the company major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

Business Description-A brief description of the company operations.

Key Employees-A list of the key executives of the company.

Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

Key Competitors-A list of the key competitors of the company.

Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company financial deals that enable you to understand the company expansion/divestiture and fund requirements

The profile enables you to analyze the company financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company business segments' expansion / divestiture strategy

The profile presents deals from the company core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company recent financial deals that enable you to understand the key deals which have shaped the company

Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

The profile analyzes the company business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications
ankur [@] kenresearch.com
+91-9015378249
www.kenresearch.com

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 5

CareDx Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 6

CareDx Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 7

CareDx Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 8

CareDx Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 9

CareDx Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 10

CareDx Inc, Medical Equipment, Deal Details 11

Venture Financing 11

CareDx Secures USD15 Million in Venture Funding 11

XDx Secures US$2.2 Million In Venture Financing 11

Private Equity 12

LinkMed Acquires 50% Stake In Olerup International From NorDiag 12

Partnerships 13

Diaxonhit Enters Into Licensing And Distribution Agreement With XDx For AlloMap Molecular Expression Testing 13

CML HealthCare And XDx Enter Into Licensing Agreement For AlloMap Heart Transplant Test 14

CareDx to Partner with Qiagen 15

CareDx Enters into Co-Development Agreement with Horizon Discovery 16

XDx Enters Into Agreement With LabCorp To Develop Lupus Flare Predictor Test 16

Olerup SSP Enters Into Distribution Agreement With Conexio Genomics 17

Olerup Enters Into Co-Marketing Agreement With QIAGEN 18

Equity Offering 19

CareDx Plans to Raise Funds through Private Placement of Shares upon Exercise of Warrants 19

CareDx Raises USD9 Million in Public Offering of Shares 20

CareDx Plans to Raise up to USD23 Million in Public offering of Shares 21

CareDx to Raise USD22 Million in Private Placement of Units 22

CareDx Raises USD14 Million in Private Placement of Units 23

CareDx to Raise USD8 Million in Private Placement of Units 24

CareDx Prices IPO for USD40 Million 26

Acquisition 27

Allenex To Sell 2.1% Stake In AnaMar To Koncentra For US$0.3 Million 27

SpinMed Completes Acquisition Of 73.4% Stake In OrtoWay From Allenex 28

CareDx Inc-Key Competitors 30

Key Employees 31

Locations And Subsidiaries 32

Head Office 32

Other Locations & Subsidiaries 32

Recent Developments 33

Financial Announcements 33

Jun 09, 2017: CareDx Reports First Quarter 2017 Financial Results 33

May 22, 2017: CareDx Reports Preliminary First Quarter 2017 Financial Results 34

Apr 21, 2017: CareDx Reports Fourth Quarter and Full Year 2016 Financial Results 35

Mar 15, 2017: CareDx Reports Preliminary Fourth Quarter and FY 2016 Financial Results 36

Nov 09, 2016: CareDx Reports Third Quarter 2016 Financial Results 38

Aug 10, 2016: CareDx Reports Preliminary Second Quarter 2016 Financial Results 39

May 06, 2016: CareDx Reports First Quarter 2016 Financial Results 41

Mar 24, 2016: CareDx Reports Fourth Quarter and Full Year 2015 Financial Results 42

Corporate Communications 43

Apr 21, 2017: CareDx Appoints Michael Bell as Chief Financial Officer 43

Jul 15, 2016: CareDx Appoints Douglas Miller to Its Board of Directors 44

Mar 29, 2016: CareDx Announces New Chief Commercial Officer Todd Whitson 45

Mar 24, 2016: CareDx Announces CFO Transition 46

Product News 47

May 30, 2017: CareDx Activities at European Federation of Immunogenetics Congress 47

Apr 28, 2016: CareDx to Present Clinical Abstracts Containing New Data at the 2016 ISHLT On AlloMap & AlloSure in heart transplant patients 48

Mar 08, 2016: CareDx Receives Positive Coverage Decision for AlloMap From TRICARE Covering Over 9 Million Lives of U.S. Military Members and Their Families 49

Jan 12, 2016: CareDx and Diaxonhit Announce Completion of Technology Transfer of AlloMap Test in Europe 50

Appendix 51

Methodology 51

About GlobalData 51

Contact Us 51

Disclaimer 51

List of Figures

CareDx Inc, Medical Equipment, Deals by Type, 2011 to YTD 2017 1

CareDx Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 1

CareDx Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 1

CareDx Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 1

CareDx Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 6

CareDx Inc, Medical Equipment, Deals by Type, 2011 to YTD 2017 7

CareDx Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 8

CareDx Inc, Medical Equipment, Deals by Market, 2011 to YTD 2017 9

List of Tables

CareDx Inc, Medical Equipment, Key Facts, 2016 1

CareDx Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 1

CareDx Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 6

CareDx Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 7

CareDx Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 8

CareDx Inc, Deals By Market, 2011 to YTD 2017 9

CareDx Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 10

CareDx Secures USD15 Million in Venture Funding 11

XDx Secures US$2.2 Million In Venture Financing 11

LinkMed Acquires 50% Stake In Olerup International From NorDiag 12

Diaxonhit Enters Into Licensing And Distribution Agreement With XDx For AlloMap Molecular Expression Testing 13

CML HealthCare And XDx Enter Into Licensing Agreement For AlloMap Heart Transplant Test 14

CareDx to Partner with Qiagen 15

CareDx Enters into Co-Development Agreement with Horizon Discovery 16

XDx Enters Into Agreement With LabCorp To Develop Lupus Flare Predictor Test 16

Olerup SSP Enters Into Distribution Agreement With Conexio Genomics 17

Olerup Enters Into Co-Marketing Agreement With QIAGEN 18

CareDx Plans to Raise Funds through Private Placement of Shares upon Exercise of Warrants 19

CareDx Raises USD9 Million in Public Offering of Shares 20

CareDx Plans to Raise up to USD23 Million in Public offering of Shares 21

CareDx to Raise USD22 Million in Private Placement of Units 22

CareDx Raises USD14 Million in Private Placement of Units 23

CareDx to Raise USD8 Million in Private Placement of Units 24

CareDx Prices IPO for USD40 Million 26

Allenex To Sell 2.1% Stake In AnaMar To Koncentra For US$0.3 Million 27

SpinMed Completes Acquisition Of 73.4% Stake In OrtoWay From Allenex 28

CareDx Inc, Key Competitors 30

CareDx Inc, Key Employees 31

CareDx Inc, Subsidiaries 32

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to query [@] kenresearch.com
 

CareDx Inc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.


Ken Research Pvt. Ltd. 27A, Tower B-2, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

query [@] kenresearch.com